ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Approve Policy On Industry Support; NCI Turns Down Request To “Launder” Contributions

December 16, 1983

Funding Opportunities

January 24, 2003

Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says

February 12, 1999

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989

Upton Prefers Keeping Bioassay Program In NCI

May 12, 1978

Also NCI prostate SPOREs plan biospecimen bank.

December 10, 2004